跳至主要内容
临床试验/IRCT20230304057615N1
IRCT20230304057615N1尚未招募Unknown

Comparing the efficacy of hydroalcoholic extract of Iranian oak (germ and seed coat) with proton pump inhibitor (PPI) treatment in improving the symptoms of patients with gastroesophageal reflux

Ahvaz University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Patients who are between 20 and 60 years old
  • Diagnosed with gastroesophageal reflux (GERD) based on clinical symptoms (having reflux at least twice a week), diagnostic endoscopy (esophagogastroduodenoscopy) and the Los Angeles classification (grades A to D)
  • Not taking PPI for at least 1 week before entering the study

排除标准

  • Patients who are infected with H. pylori in the initial diagnostic examinations and before the intervention, based on stomach biopsy or stool test
  • Patients with coagulation disorders or GI bleeding
  • Patients who have a history of upper GI surgery or suffer from other digestive diseases such as irritable bowel syndrome, peptic ulcer, obstructive disease, etc
  • Patients with Zollinger-Ellison syndrome, primary motility disorders, Barrett's esophagus, esophageal stricture, and any severe disease with reflux and malignancy of the upper gastrointestinal tract, as well as pregnant or lactating women
  • Patients who take PPIs from 28 days before diagnostic endoscopy or H2 receptor antagonists from 14 days before diagnostic endoscopy
  • Patients who take NSAIDs or other drugs that may interfere with the interpretation of the study result. (diazepam, quinidine, Dilantin, warfarin, anticholinergics, prostaglandin analogs, or sucralfate)
  • Patients with chronic kidney, lung, and liver diseases and ...
  • Patients who have a history of sensitivity to pantoprazole or seasonal allergies or asthma
  • Patients who consume alcohol or drugs

研究者

相似试验

Evaluation of the effect of hydroalcoholic extract... | 临床试验